Simplex Trading, LLC Keros Therapeutics, Inc. Transaction History
Simplex Trading, LLC
- $175 Billion
- Q2 2025
A detailed history of Simplex Trading, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 90,735 shares of KROS stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,735
Previous 70,512
28.68%
Holding current value
$1.31 Million
Previous $718,000
68.66%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding KROS
# of Institutions
181Shares Held
36.7MCall Options Held
938KPut Options Held
1.39M-
Nuveen, LLC Charlotte, NC3.95MShares$56.8 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$37.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$36.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$36.2 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA2MShares$28.8 Million3.97% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $371M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...